Asphalion
Asphalion is a Barcelona-headquartered international regulatory and scientific affairs consultancy serving 1,500+ pharmaceutical, biotechnology, and medical device clients across 50+ countries, offering end-to-end drug and device regulatory, pharmacovigilance, CMC, and MedTech services from four European offices.
- Company typePrivate
- Founded2000
- HeadquartersBarcelona, Spain
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Asphalion does
Asphalion, S.L. is an international Scientific, Safety and Regulatory Affairs consultancy founded in 2000 in Barcelona, Spain, with additional offices in Madrid, Munich, and London and a team of more than 200 professionals across 16 nationalities. The company serves pharmaceutical, biotechnology, and medical device developers — plus EU Horizon-funded research consortia — with end-to-end regulatory services spanning drug development consulting, medical and scientific writing, CMC, regulatory procedures (EMA, FDA, MHRA, Swissmedic), pharmacovigilance and medical-device vigilance, regulatory operations (eCTD publishing and data management), MedTech, HTA Regulation support, and training. Notable milestone engagements include 18 EMA Centralised Procedures and the 2024 BIMERVAX vaccine approval; the firm has served over 1,500 client companies across 50+ countries and executed more than 10,000 projects. Its certifications include ISO 9001:2015 (covering pharmacovigilance), ISO 13485:2016 (medical devices), and ISO 27001:2022 (information security).
Asphalion's technology stack combines traditional consulting workflows with a proprietary suite of AI-tagged digital tools — AsphaSearch (AI-powered global literature monitoring), AsphaAlerts (regulatory intelligence automation), AsphaDigiMedia (social-media adverse-reaction screening), and AsphaTriage (case triage) — supported by a validated Safety Database used both for client services and the firm's own PV system. The company also operates Asphanet, a pan-European partner network for local regulatory coverage, and an AI Ethic Code governance framework.
The business model is professional-services B2B: project-based, quote-priced engagements sold directly to enterprise pharma, biotech, and MedTech clients through senior-led consulting relationships, supplemented by recurring PV/QPPV mandates (currently 90+ companies) and Asphalion Knowledge Centre training. Long-cycle regulatory dossiers and ongoing safety obligations generate multi-year revenue stickiness, while the Asphanet partner channel extends geographic reach without proportional headcost. Asphalion has grown organically since founding, with no disclosed external funding, M&A, or institutional investors.
Asphalion firmographics
Firmographics- Name
- Asphalion
- Legal name
- ASPHALION, S.L.
- Website
- https://asphalion.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Asphalion is a Barcelona-headquartered international regulatory and scientific affairs consultancy serving 1,500+ pharmaceutical, biotechnology, and medical device clients across 50+ countries, offering end-to-end drug and device regulatory, pharmacovigilance, CMC, and MedTech services from four European offices.
- Ownership category
- akta.pro rank
Asphalion industry classification
Industry- Product category
- Regulatory and Scientific Affairs Consulting (Life Sciences)
- NAICS
- Management, Scientific, and Technical Consulting Services (5416), Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (54)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)
- akta.pro secondary industries
- Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC), Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF), Inspection Readiness & Regulatory Authority Support (FDA/EMA/MHRA) (HLAGAKAF), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
Keywords
Where Asphalion is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices4 records
Markets served
Asphalion business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Regulatory Affairs Consulting Services: Expert consulting and strategic advice services for regulatory affairs, scientific writing, CMC, drug development, and regulatory procedures. Provided across all product lifecycle stages for pharmaceuticals, biologics, ATMPs, and medical devices.
- Regulatory Operations Services: Electronic submissions, eCTD publishing, data management, and regulatory operations support. Includes managing over 1,500 eCTD sequences per year.
- Pharmacovigilance Services: Comprehensive pharmacovigilance support including EU-QPPV services, local PV support, aggregate safety reports, ICSR management, and PV system management. Currently supports more than 90 companies.
- MedTech Regulatory Services: Full regulatory and quality management support for medical devices including CE certification, technical documentation, clinical evaluation reports, QMS audits, and PRRC services.
- Training and Knowledge Services: Asphalion Knowledge Centre provides training courses for biotech, pharma and medtech industry professionals on EU and US regulations.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Asphalion product offering
Product offeringCore offering
Asphalion is an international Scientific, Safety and Regulatory Affairs consultancy that delivers expert consulting, strategic advisory, operational support, and full outsourcing services for pharmaceutical, biotechnological, and medical device products across all lifecycle stages. Core deliverables include regulatory procedures (EMA Centralised, MRP, DCP, FDA), scientific and medical writing, CMC, drug development consulting, pharmacovigilance and vigilance, regulatory operations (eCTD publishing, eSubmissions, data management), MedTech (MDR/IVDR, CE marking, PRRC), HTA, and Horizon Europe programme support.
Product overview
Asphalion is an international Scientific, Safety and Regulatory Affairs consultancy company offering expert consulting, strategic advice, operational support, and full outsourcing services for all product life cycle stages of medicines and medical devices. The company operates as a unified platform with multiple integrated service units: Medical and Scientific Writing, Drug Development Consulting, CMC, Regulatory Procedures, Pharmacovigilance and Medical Devices Vigilance, Regulatory Operations (eCTD Publishing/eSubmissions and Data Management), MedTech, Horizon Europe Programmes, and HTA services. Asphalion also offers specialized digital tools including AsphaSearch (AI-powered literature searches), AsphaAlerts (regulatory intelligence), AsphaDigiMedia (social media screening), and AsphaTriage for pharmacovigilance activities, plus training services through Asphalion Knowledge Centre and a European partner network via Asphanet.
Differentiator
Problem solved
Functional benefit
Brands
- Asphalion MedTech: Comprehensive support for worldwide Medical Device Regulations, covering the full range of MedTech services including regulatory strategy, CE certification, quality management systems, and PRRC services.
- Asphalion Knowledge Centre
- AsphaSearch
- AsphaAlerts
- AsphaDigiMedia
- AsphaTriage
Quantifiable outcome
- Over 10,000 projects delivered for 1,500+ clients across 50+ countries
- +5 more outcomes
Companies that use Asphalion
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Asphalion technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
Asphalion partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and major.
- European Universities and Research InstitutionscoreAsphalion serves as regulatory partner in Horizon Europe funded projects, collaborating with leading universities including University of Santiago de Compostela, Wageningen University, UPV, Aarhus University, University of Liverpool, Tampere University, Vall d'Hebron Institute of Oncology, and 15+ others.
- ExtedocoreOver 10-year partnership with Extedo for regulatory publishing software. Asphalion uses Extedo tools (eCTD Manager, EURS Validator, eSUBManager) for publishing activities and provides customer support on their behalf for regional clients.
- Asphanet European NetworkcoreNetwork of partners providing local regulatory services throughout Europe including EU Local, Spain, UK, Switzerland, and other regional regulatory requirements. Allows Asphalion to offer comprehensive EU coverage.
- Veeva SystemsmajorVeeva Certified Partner for regulatory and quality cloud solutions, participating in Veeva R&D and Quality Summit Europe events.
- EMA Subject Matter ExpertsmajorRegular collaboration with European Medicines Agency Subject Matter Experts for regulatory submissions and industry guidance.
- Notified BodiescoreSupport for clients in selection of adequate Notified Bodies for medical device CE certification, and assistance during Notified Body audits.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Asphalion competitors and assessment
Company assessmentOthers
- Veeva Systems: Provider of regulatory information management (RIM), quality and clinical software (Asphalion is a Veeva Certified Partner). Not a direct services competitor but an enabling technology platform whose product roadmap shapes Asphalion's digital toolset.
Broad incumbents
- Parexel: Major global CRO with a regulatory and pharmacovigilance consulting practice covering EMA, FDA and global submissions. Competes for large enterprise regulatory outsourcing deals that Asphalion also targets.
- NSF (formerly NSF Health Sciences): Large, established provider of regulatory and quality consulting, training and certification for pharma, biotech and MedTech globally. Overlaps with Asphalion's regulatory/quality and training offerings (Asphalion Knowledge Centre) but operates at much greater scale across broader industries.
- Labcorp Drug Development (formerly Covance): Global CRO with a sizeable regulatory affairs and pharmacovigilance service line alongside its clinical and bioanalytical core. Competes with Asphalion on enterprise regulatory outsourcing mandates and FDA-facing projects.
- ICON plc: Global CRO with growing regulatory affairs and pharmacovigilance capabilities post-PRA Health Sciences and Symphony Health acquisitions. Adjacent competitor when mid-size pharma seek bundled regulatory + clinical engagements.
Direct peers
- Arriello: Specialist EU regulatory affairs, pharmacovigilance and quality/CMC consultancy serving pharma and biotech clients. Similar in scale, service mix and EU-centric customer base to Asphalion.
- Voisin Consulting Life Sciences: European regulatory affairs and clinical development consultancy with deep expertise in EMA/FDA submissions, MedTech, and pharmacovigilance. Closely comparable in service portfolio and target customers to Asphalion.
- ProPharma Group: Global regulatory, compliance and pharmacovigilance consulting firm serving pharma, biotech and MedTech companies. Overlapping services in regulatory strategy, PV, CMC, and quality management make it a direct peer.
- PharmaLex: One of the largest specialist regulatory affairs, pharmacovigilance and CMC consultancies in Europe with similar full-lifecycle regulatory services for pharma and biotech. Directly comparable to Asphalion in service scope, customer type (mid-size pharma/biotech) and EU-centric footprint.
Emerging players
- Real Regulatory: European regulatory affairs consultancy focused on regulatory strategy, submissions and CMC for biotech and specialty pharma. Smaller than Asphalion but overlaps materially in service scope and target customer profile.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Asphalion social profiles
Digital presenceAsphalion compliance and trust
Trust signalCompliance6 records
Asphalion financial estimates
Financial estimateRevenue estimate
Valuation estimate
Asphalion leadership team
Management profileNumber of profiles
Profiles8 records
Asphalion funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Asphalion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Asphalion
What does Asphalion do?
Asphalion is an international Scientific, Safety and Regulatory Affairs consultancy that delivers expert consulting, strategic advisory, operational support, and full outsourcing services for pharmaceutical, biotechnological, and medical device products across all lifecycle stages. Core deliverables include regulatory procedures (EMA Centralised, MRP, DCP, FDA), scientific and medical writing, CMC, drug development consulting, pharmacovigilance and vigilance, regulatory operations (eCTD publishing, eSubmissions, data management), MedTech (MDR/IVDR, CE marking, PRRC), HTA, and Horizon Europe programme support.
Is Asphalion a public or private company?
Asphalion is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Asphalion founded?
Asphalion was founded in 2000. It employs 101 to 250 people.
Where is Asphalion based?
Asphalion is headquartered in Barcelona, Spain, in the Europe region.
How does Asphalion make money?
Five revenue lines are on record. Regulatory Affairs Consulting Services are the primary driver. The others are regulatory Operations Services, pharmacovigilance Services, medTech Regulatory Services and training and Knowledge Services.
Who are Asphalion's main competitors?
Veeva Systems is listed as an others. Broad incumbents are Parexel, NSF (formerly NSF Health Sciences), Labcorp Drug Development (formerly Covance) and ICON plc. Direct peers are Arriello, Voisin Consulting Life Sciences, ProPharma Group and PharmaLex. Real Regulatory is listed as an emerging player.
Does Asphalion have an API?
No public API is recorded for Asphalion.
What industry is Asphalion in?
Asphalion's product category is Regulatory and Scientific Affairs Consulting (Life Sciences). Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAGAKAC, Regulatory Operations & Publishing (eCTD, RIM, Submission Management). Its NAICS code is 5416 and its SIC code is 8731.